| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.23 | 2e-08 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-05 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.0003 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0004 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |